CFO
GLSI icon

CVA Family Office’s Greenwich LifeSciences GLSI Stock Holding History

CVA Family Office’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240 Buy
+10
New +$261 ﹤0.01% 1804

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

CVA Family Office's GLSI Position: Q1 2026 in Review

CVA Family Office opened a new position in Greenwich LifeSciences (GLSI) in Q1 2026: 10 shares worth $240. The stake represents ﹤0.01% of the portfolio and ranks #1804 among its holdings.

64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • CVA Family Office held 10 shares of Greenwich LifeSciences worth $240 as of Q1 2026.
  • Greenwich LifeSciences was a new CVA Family Office position in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1804 holding.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.